CANTONI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 3.617
AS - Asia 2.071
EU - Europa 1.397
SA - Sud America 415
Continente sconosciuto - Info sul continente non disponibili 85
AF - Africa 59
OC - Oceania 6
Totale 7.650
Nazione #
US - Stati Uniti d'America 3.442
SG - Singapore 763
CN - Cina 529
IT - Italia 446
BR - Brasile 336
DE - Germania 236
HK - Hong Kong 217
VN - Vietnam 176
BD - Bangladesh 119
GB - Regno Unito 114
UA - Ucraina 103
FR - Francia 99
FI - Finlandia 92
RU - Federazione Russa 83
CA - Canada 81
TR - Turchia 68
IN - India 56
IE - Irlanda 47
NL - Olanda 37
MX - Messico 33
AR - Argentina 29
CZ - Repubblica Ceca 25
JP - Giappone 24
BE - Belgio 22
ZA - Sudafrica 18
EC - Ecuador 17
PL - Polonia 16
AT - Austria 14
SE - Svezia 14
ID - Indonesia 12
IQ - Iraq 12
PK - Pakistan 12
UZ - Uzbekistan 12
ES - Italia 11
IL - Israele 11
HN - Honduras 10
VE - Venezuela 10
EG - Egitto 9
CO - Colombia 8
MA - Marocco 8
SA - Arabia Saudita 8
CR - Costa Rica 7
EE - Estonia 7
JM - Giamaica 7
LT - Lituania 7
NI - Nicaragua 7
SV - El Salvador 7
TW - Taiwan 7
AU - Australia 6
LB - Libano 6
PY - Paraguay 6
TN - Tunisia 6
GP - Guadalupe 5
IR - Iran 5
RO - Romania 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CW - ???statistics.table.value.countryCode.CW??? 4
JO - Giordania 4
KE - Kenya 4
PA - Panama 4
PE - Perù 4
CH - Svizzera 3
ET - Etiopia 3
GT - Guatemala 3
KG - Kirghizistan 3
MY - Malesia 3
PR - Porto Rico 3
TH - Thailandia 3
BG - Bulgaria 2
CG - Congo 2
CL - Cile 2
DO - Repubblica Dominicana 2
GA - Gabon 2
LV - Lettonia 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
RS - Serbia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
DK - Danimarca 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GM - Gambi 1
HR - Croazia 1
HU - Ungheria 1
KR - Corea 1
KZ - Kazakistan 1
Totale 7.558
Città #
Singapore 417
Ashburn 294
San Jose 260
Hong Kong 217
Fairfield 192
Council Bluffs 168
New York 162
Chandler 136
The Dalles 133
Beijing 130
Los Angeles 103
Woodbridge 102
Houston 81
Jacksonville 80
Dallas 76
Munich 75
Ann Arbor 67
Seattle 67
Helsinki 65
Ho Chi Minh City 65
Cambridge 62
Princeton 58
São Paulo 57
Wilmington 57
Lauterbourg 55
Istanbul 52
Dublin 46
North Bergen 43
Santa Clara 41
Milan 39
Columbus 37
Rome 37
Chicago 36
Hanoi 35
San Francisco 31
Des Moines 29
Shanghai 28
Buffalo 26
Nanjing 26
Montreal 25
Redondo Beach 25
Brescia 24
Moscow 24
Atlanta 23
London 23
Nuremberg 23
Phoenix 23
Tokyo 23
Turku 23
Brussels 21
Boardman 18
Chennai 18
Brooklyn 16
Dearborn 16
Mexico City 16
Mumbai 16
Rio de Janeiro 16
Denver 14
Olomouc 14
Orem 14
Amsterdam 13
Charlotte 13
Frankfurt am Main 13
Toronto 13
Warsaw 13
Boston 12
Johannesburg 12
Naples 12
Jinan 11
Manchester 10
Romola 10
San Diego 10
Tashkent 10
Turin 10
Dhaka 9
Lucca 9
Nanchang 9
Philadelphia 9
Brno 8
Guangzhou 8
Haiphong 8
Las Vegas 8
Vienna 8
Ankara 7
Bari 7
Brasília 7
Calgary 7
Florence 7
Managua 7
Palermo 7
Quito 7
San Mateo 7
San Salvador 7
Changsha 6
Da Nang 6
Hangzhou 6
Hebei 6
Honolulu 6
Perugia 6
Poplar 6
Totale 4.450
Nome #
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 250
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 244
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 218
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 197
The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease 196
Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia 182
Enhancing theory of mind in behavioural variant frontotemporal dementia with transcranial direct current stimulation 176
The impact of TMS on the differential diagnosis and progression of dementia 148
Modulating risky decision-making in Parkinson's disease by transcranial direct current stimulation. 144
Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial 143
Cerebello-spinal stimulation in neurodegenerative ataxia: A randomized, double-blind, sham-controlled, crossover trial 140
Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: Impact on diagnostic confidence and diagnostic accuracy 139
Clinical and neurophysiological characteristics of heterozygous NPC1 carriers 138
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 137
Classification accuracy of TMS for the diagnosis of mild cognitive impairment 137
TMS for staging and predicting functional decline in frontotemporal dementia 136
Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72 134
Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative Dementias 133
Cortical Inhibitory Imbalance in Functional Paralysis 131
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 131
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 129
Modulation of long-term potentiation-like cortical plasticity in the healthy brain with low frequency-pulsed electromagnetic fields 127
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 127
Neuropsychiatric Symptoms in Frontotemporal Dementia: More Than Just Noise? 125
Exposure to gamma tACS in Alzheimer's disease: A randomized, double-blind, sham-controlled, crossover, pilot study 125
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 123
Differences and similarities between familial and sporadic frontotemporal dementia: An Italian single-center cohort study 122
Transcranial stimulation in frontotemporal dementia: A randomized, double-blind, sham-controlled trial 121
Disclosure of plasma p-tau217 measure improves diagnostic confidence in patients with Alzheimer's disease versus syndromes associated with frontotemporal lobar degeneration 119
Motor and cognitive outcomes of cerebello-spinal stimulation in neurodegenerative ataxia 117
Comparing Cerebellar tDCS and Cerebellar tACS in Neurodegenerative Ataxias Using Wearable Sensors: A Randomized, Double-Blind, Sham-Controlled, Triple-Crossover Trial 114
Biomarker discovery in Alzheimer's and neurodegenerative diseases using Nucleic Acid Linked Immuno-Sandwich Assay 114
Citicoline Treatment in Acute Ischemic Stroke: A Randomized, Single-Blind TMS Study 112
Neurophysiological Correlates of Positive and Negative Symptoms in Frontotemporal Dementia 112
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 111
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 108
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 102
Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias 100
The role of transcranial magnetic stimulation in the diagnosis of dementia 100
Neurophysiological correlates of altered time awareness in Alzheimer's disease and frontotemporal dementia 100
Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration 100
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort 99
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 96
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia 95
Differential early subcortical involvement in genetic FTD within the GENFI cohort 94
Cortico-spinal tDCS in amyotrophic lateral sclerosis: A randomized, double-blind, sham-controlled trial followed by an open-label phase 93
Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease 92
Time to Diagnosis and Its Predictors in Syndromes Associated With Frontotemporal Lobar Degeneration 85
Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia 83
Neurophysiological Correlates of Motor and Cognitive Dysfunction in Prodromal and Overt Dementia with Lewy Bodies 80
Neurotransmitter imbalance dysregulates brain dynamic fluidity in frontotemporal degeneration 80
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 80
Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study 79
Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design 79
Impaired spatial dynamic functional network connectivity and neurophysiological correlates in functional hemiparesis 77
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 76
Plasma p-tau217 and neurofilament/p-tau217 ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration 68
Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial 68
Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype 66
Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis 65
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology 64
Anatomical progression of genetic frontotemporal lobar degeneration across the lifespan 64
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 60
Language impairment in the genetic forms of behavioural variant frontotemporal dementia 58
Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study 51
Predicting survival rate by plasma biomarkers and clinical variables in syndromes associated with frontotemporal lobar degeneration 40
Mapping the multiscale neuroanatomy of GRN-related frontotemporal dementia using mode-based morphometry 39
The detection of GRN mutation carriers by progranulin blood protein levels from finger-stick collection 34
Thalamus involvement in genetic frontotemporal dementia assessed using structural and diffusion MRI: A GENFI study 23
Totale 7.650
Categoria #
all - tutte 40.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.637


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022212 0 0 0 0 3 11 24 28 20 27 38 61
2022/2023396 36 26 19 29 30 89 4 41 64 1 30 27
2023/2024521 31 18 69 29 9 97 9 29 93 26 14 97
2024/20251.338 17 8 16 215 104 109 88 64 179 147 228 163
2025/20263.038 260 327 233 425 283 188 372 128 205 280 189 148
2026/2027996 115 153 184 492 52 0 0 0 0 0 0 0
Totale 7.650